New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Increasing incidence of early-onset colorectal precancerous lesions in patients under age 50

Increasing incidence of early-onset colorectal precancerous lesions in patients under age 50

by The Mount Sinai HospitalCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0In a study published in the journalGastroenterology, researchers at the Icahn Sch
Gastroenterology February 19,2024
Increasing incidence of early-onset colorectal precancerous lesions in patients under age 50

Increasing incidence of early-onset colorectal precancerous lesions in patients under age 50

by The Mount Sinai HospitalCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0In a study published in the journalGastroenterology, researchers at the Icahn Sch
Gastroenterology February 19,2024
A novel pathway to target colorectal cancer

A novel pathway to target colorectal cancer

by Medical University of South CarolinaDr. Raymond N. Dubois, noted cancer researcher and dean of the College of Medicine at the Medical University of South Carolina, is senior author on the Gast
Gastroenterology February 19,2024
A novel pathway to target colorectal cancer

A novel pathway to target colorectal cancer

by Medical University of South CarolinaDr. Raymond N. Dubois, noted cancer researcher and dean of the College of Medicine at the Medical University of South Carolina, is senior author on the Gast
Gastroenterology February 19,2024
Ammonia levels do not aid management of hepatic encephalopathy in cirrhotic patients

Ammonia levels do not aid management of hepatic encephalopathy in cirrhotic patients

by Medical University of South CarolinaDon Rockey, M.D. is professor and chair of the Department of Medicine at the Medical University of South Carolina. Credit: Sarah PackThe liver performs seve
Gastroenterology February 19,2024
Ammonia levels do not aid management of hepatic encephalopathy in cirrhotic patients

Ammonia levels do not aid management of hepatic encephalopathy in cirrhotic patients

by Medical University of South CarolinaDon Rockey, M.D. is professor and chair of the Department of Medicine at the Medical University of South Carolina. Credit: Sarah PackThe liver performs seve
Gastroenterology February 19,2024
Factors associated with nonresponse to FMT identified in IBS

Factors associated with nonresponse to FMT identified in IBS

For patients with irritable bowel syndrome (IBS), those who are male and/or have low Alistipes levels are more likely to be nonresponders to fecal microbiota transplantation (FMT), according to a stud
Gastroenterology February 19,2024
Factors associated with nonresponse to FMT identified in IBS

Factors associated with nonresponse to FMT identified in IBS

For patients with irritable bowel syndrome (IBS), those who are male and/or have low Alistipes levels are more likely to be nonresponders to fecal microbiota transplantation (FMT), according to a stud
Gastroenterology February 19,2024
Does TikTok's chia-lemon 'internal shower' really beat constipation? Here's what science says

Does TikTok's chia-lemon 'internal shower' really beat constipation? Here's what science says

by Clare Collins,The ConversationCredit: AI-generated imageHeard about the chia seed-lemon juice "internal shower" drink? It's going viral on TikTok and is being hailed as a digest
Gastroenterology February 19,2024
Does TikTok's chia-lemon 'internal shower' really beat constipation? Here's what science says

Does TikTok's chia-lemon 'internal shower' really beat constipation? Here's what science says

by Clare Collins,The ConversationCredit: AI-generated imageHeard about the chia seed-lemon juice "internal shower" drink? It's going viral on TikTok and is being hailed as a digest
Gastroenterology February 19,2024
Alzheimer's breakthrough: Genetic link to gut disorders confirmed

Alzheimer's breakthrough: Genetic link to gut disorders confirmed

by Edith Cowan UniversityClusters of significantly enriched biological pathways for AD and GERD.aKEGG: Kyoto Encyclopedia of Genes and Genomes pathways:intestinal immune network
Gastroenterology February 19,2024
Alzheimer's breakthrough: Genetic link to gut disorders confirmed

Alzheimer's breakthrough: Genetic link to gut disorders confirmed

by Edith Cowan UniversityClusters of significantly enriched biological pathways for AD and GERD.aKEGG: Kyoto Encyclopedia of Genes and Genomes pathways:intestinal immune network
Gastroenterology February 19,2024
Upadacitinib superior to placebo in moderate-to-severe Crohn disease

Upadacitinib superior to placebo in moderate-to-severe Crohn disease

by Elana GotkineFor patients with moderate-to-severe Crohn disease, upadacitinib induction and maintenance treatment are superior to placebo, according to a study published in the May 25 issue of the&
Gastroenterology February 19,2024
Upadacitinib superior to placebo in moderate-to-severe Crohn disease

Upadacitinib superior to placebo in moderate-to-severe Crohn disease

by Elana GotkineFor patients with moderate-to-severe Crohn disease, upadacitinib induction and maintenance treatment are superior to placebo, according to a study published in the May 25 issue of the&
Gastroenterology February 19,2024
ChatGPT does not pass American College of Gastroenterology tests

ChatGPT does not pass American College of Gastroenterology tests

by Elana GotkineThe natural language processing model Chat Generative Pretrained Transformer (ChatGPT) does not pass the American College of Gastroenterology (ACG) Self-Assessment Tests, according to
Gastroenterology February 19,2024
ChatGPT does not pass American College of Gastroenterology tests

ChatGPT does not pass American College of Gastroenterology tests

by Elana GotkineThe natural language processing model Chat Generative Pretrained Transformer (ChatGPT) does not pass the American College of Gastroenterology (ACG) Self-Assessment Tests, according to
Gastroenterology February 19,2024
FDA approves first pill to treat moderate-to-severe Crohn's disease

FDA approves first pill to treat moderate-to-severe Crohn's disease

by Cara MurezPatients with Crohn's disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib).Rinvoq is meant to treat adults
Gastroenterology February 19,2024
FDA approves first pill to treat moderate-to-severe Crohn's disease

FDA approves first pill to treat moderate-to-severe Crohn's disease

by Cara MurezPatients with Crohn's disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib).Rinvoq is meant to treat adults
Gastroenterology February 19,2024
ACG issues guideline for management of upper GI bleeding

ACG issues guideline for management of upper GI bleeding

(HealthDay)—In an American College of Gastroenterology clinical guideline, published in the May issue of theAmerican Journal of Gastroenterology, recommendations are presented for the mana
Gastroenterology February 19,2024
ACG issues guideline for management of upper GI bleeding

ACG issues guideline for management of upper GI bleeding

(HealthDay)—In an American College of Gastroenterology clinical guideline, published in the May issue of theAmerican Journal of Gastroenterology, recommendations are presented for the mana
Gastroenterology February 19,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com